通过调节肠道微生物群的抗糖尿病作用的多糖类的最新进展:来源,机制和结构-活动关系
Xiaoyu Zhang1, Jia Wang1, Tingting Zhang1
1Tianjin Key Laboratory for Modern Drug Delivery and High-Efficiency, School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin 300072, China.
自然的多糖类可以通过调节肠道微生物群来改善糖尿病 (DM). 本综述探讨了它们的来源,抗糖尿病作用和机制,强调了未来发展的结构-活动关系.
科学领域:
- 代谢性疾病是一种代谢性疾病.
- 微生物组研究的研究.
- 自然产品化学 自然产品化学
背景情况:
- 糖尿病 (DM) 是全球普遍存在的慢性代谢障碍.
- 肠道微生物群失调与DM发展密切相关.
- 自然的多糖体具有显著的抗糖尿病特性.
研究的目的:
- 审查天然多糖的来源,抗糖尿病作用和肠道微生物群调节功能.
- 总结聚糖类调节肠道微生物群的机制,以获得抗糖尿病的结果.
- 分析多糖的结构-活性关系,以了解它们的抗糖尿病潜力.
主要方法:
- 文献综述总结了关于天然多糖和糖尿病的现有研究.
- 对专注于肠道微生物群和多糖酸发酵之间的相互作用的研究进行分析.
- 基于多糖的化学特征,检查多糖的结构-活性关系.
主要成果:
- 来自不同来源 (植物,真菌,海洋生物) 的多糖体表现出强大的低血糖活性.
- 机制包括肠道屏障修复,微生物群组成调节,代谢物改变和免疫/炎症调节.
- 多糖的结构特征 (单糖组成,分子量,糖链) 显著影响抗糖尿病功效.
结论:
- 天然多糖是通过肠道微生物群调节来管理糖尿病的有希望的药物.
- 了解结构-活性关系对于开发基于多糖的新型抗糖尿病疗法至关重要.
- 本综述作为进一步研究和开发在这个领域的参考.
更多相关视频
13:35Structural Biology and Analytical Chemistry Approaches for Characterizing C-Glycoside Metabolic Enzymes in Human Gut Microbiota
Published on: May 23, 2025
12:02Automated Modular High Throughput Exopolysaccharide Screening Platform Coupled with Highly Sensitive Carbohydrate Fingerprint Analysis
Published on: April 11, 2016
相关概念视频
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Dipeptidyl Peptidase 4 Inhibitors
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Oral Hypoglycemic Agents: Biguanides and Glitazones
